abstract |
METABOLISM MODULATORS AND THE TREATMENT OF DISORDERS RELATED TO THEME. The present invention relates to 4- {5-Methoxy-6- (2-methyl-6- [1,2,4 {triazol-1-yl-pyridin-3-ylamino) -pyrimidin-4-acid isopropyl ester -oxyoxy] -pyrimidin-4-yloxy] -piperidine-1-carboxylic, pharmaceutically acceptable salts, solvates and hydrates thereof which are modulators of glucose metabolism. Accordingly, the compounds of the present invention are useful in the treatment of related metabolic disorders and complications thereof, such as diabetes and obesity. |